Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$27.19 +0.19 (+0.70%)

Closing price 09/3/2026 04:10 PM Eastern

Extended Trading

$27.19 +0.00 (+0.01%)

As of 04:01 AM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Regeneron Pharmaceuticals. The top 22 THNR holdings ordered by weight make up 100.03% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 22 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$47.45 +1.5%	9.25%	10,466
2	LLY Eli Lilly and Company	$1,160.98 +0.1%	9.08%	397
3	REGN Regeneron Pharmaceuticals	$843.47 -1.0%	6.13%	402
4	AMGN Amgen	$444.12 +0.3%	5.48%	694
5	SRRK Scholar Rock	$55.94 -0.3%	5.36%	5,340
6	ARWR Arrowhead Pharmaceuticals	$86.49 +1.3%	5.19%	3,207
7	MRK Merck & Co., Inc.	$152.32 +0.4%	5.07%	1,977
8	ABBV AbbVie	$260.69 -0.4%	5.04%	1,062
9	PFE Pfizer	$28.82 -0.7%	4.75%	9,377
10	VKTX Viking Therapeutics	$33.98 +1.4%	4.51%	7,239
11	HIMS Hims & Hers Health	$27.77 -3.2%	4.50%	8,264
12	KLRA Kailera Therapeutics	$15.74 -0.7%	1.95%	5,732
13	Innovent Biologics, Inc.	N/A	5.85%	25,500
14	CSPC Pharmaceutical Group Limited	N/A	5.54%	260,000
15	Roche Holding AG	N/A	5.11%	605
16	Chugai Pharmaceutical Co., Ltd.	N/A	4.35%	5,100
17	Zealand Pharma A/S	N/A	4.03%	4,047
18	AstraZeneca PLC	N/A	4.01%	1,348
19	Hanmi Pharm. Co., Ltd.	N/A	2.13%	402
20	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.09%	15,800
21	Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class	N/A	0.37%	19,635
22	OTHER ASSETS AND LIABILITIES	N/A	0.24%	202,432,169

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 67.2%, followed by Cayman Islands at 6.2%.

United States
67.2%
Cayman Islands
6.2%
Hong Kong
5.7%
Japan
4.1%
United Kingdom
4.1%
Denmark
3.5%
Korea, Republic of
2.6%

THNR Currency Exposure

THNR's largest currency exposure is USD at 70.6%, followed by HKD at 13.5%.

USD
70.6%
HKD
13.5%
JPY
4.1%
DKK
3.5%
KRW
2.6%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 91.1%.

Health Care
91.1%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 86.7%, followed by Health Care Providers & Services at 4.4%.

Biotechnology
86.7%
Health Care Providers & Services
4.4%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 86.7%, followed by Health Care Services at 4.4%.

Biotechnology
86.7%
Health Care Services
4.4%

Related Companies and Tools

Related Companies

MarketBeat tracks Amplify Weight Loss Drug & Treatment ETF holdings and portfolio composition, last updated on 8/31/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List